{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P83099",
      "entity_text" : "PKCdelta",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P98160",
      "entity_text" : "PLC",
      "entity_type" : "protein"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "Furthermore, U-50,488 treatment increased the translocation of PKCdelta-EGFP from 11% +/- 2% to 47% +/- 5% and 15% +/- 3% to 70% +/- 9% after a prior pre-incubation in gallein (100 muM), a G betagamma inhibitor, and PTX (200 ng/mL), respectively (XREF_FIG), suggesting that PLC mediates PKCdelta activation by KOR in a G betagamma - and G alphai -independent process.",
  "reading_complete" : "2020-08-08T19:41:37Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T19:39:56Z",
  "trigger" : "mediates",
  "evidence" : [ "PLC mediates PKCdelta" ],
  "pmc_id" : "5937707",
  "score" : 0
}